To homepage
4.6/5
TrustPilot

Best Target therapy for lung cancer doctors in Istanbul: TOP 9 doctors

Compare top Target therapy for lung cancer doctors and prices in Turkey. Find your best match here.

Get quotes from 3 top Target therapy for lung cancer specialists in Turkey

We'll hand-pick the best doctors based on your needs and budget.

Meet the experts behind this page

Top doctors

9

Turkey

Reviews

14,000+

From real patients

Choose the country with the best prices for doctors' services

Compare prices for Target therapy for lung cancer across top countries

Tap a country to view top doctors and prices

South Korea
Spain
Germany
Turkey
$3,100 - $3,600
$3,400 - $11,700
$4,000 - $4,100
$5,000 - $5,700
$0
$2,000
$4,000
$6,000
$8,000
$10,000
$12,000

Get free personalized treatment plans and choose the best option. No commitment · No payments for our services

Show first:

55 people have requested a quote last month

Eda Tanrikulu

  • 5 Excellent 2 reviews
  • 21 years of experience
  • Location: Turkey, Istanbul
  • Specializes in medical oncology and chemotherapy at Anadolu Medical Center – excels in targeted therapies for lung cancer.

    • Completed medical oncology training at Marmara University
    • Placed 3rd in Turkey's medical oncology specialty exam
    • Led international clinical studies in medical oncology
    • Former head of medical oncology at Haydarpaşa Numune Hospital
  • Read more
Doctor's visit
Price on request

32 people have requested a quote last month

Mustafa Solak

  • 5 Excellent 1 review
  • 20 years of experience
  • Location: Turkey, Istanbul
  • Dr. Solak specializes in lung cancer treatment with fellowship training at Hacettepe University Cancer Institute, one of Turkey's leading oncology centers.

    • Trained at The University of Texas MD Anderson Cancer Center
    • Experience with targeted therapies for various cancers including lung cancer
    • Specializes in breast, ovarian, and gastrointestinal cancers as well
    • Graduated from Hacettepe University – Turkey's top medical school
  • Read more
Package price from$5,000

Tahsin Ozatli

  • 2016 years of experience
  • Location: Turkey, Istanbul
  • Specializes in breast, lung, and gastrointestinal cancers – Dr. Ozatli brings targeted expertise to complex oncology cases at Istinye Liv University Hospital.

    • Associate Professor since 2016
    • Experience across multiple oncology departments in Turkey
    • Trained at Selcuk University Faculty of Medicine
  • Read more
Doctor's visit
Price on request

Cemil Bilir

  • 21 years of experience
  • Location: Turkey, Istanbul
  • Professor Cemil Bilir specializes in targeted therapies for lung cancer at VM Medical Park Pendik Hospital. His research includes advanced treatments at Northeastern University's Center for Pharmaceutical Biotechnology.

    • Board-certified in medical oncology with 21 years of experience of experience
    • Member of ASCO and ESMO – stays updated on global oncology standards
    • Academic professor training future oncologists at Sakarya University
    • Research background in pharmaceutical biotechnology enhances treatment options
  • Read more
Doctor's visit
Price on request

Ercan Ozden

  • 27 years of experience
  • Location: Turkey, Istanbul
  • Dr. Ozden specializes in medical oncology with a focus on lung cancer treatment at VM Medical Park Pendik Hospital.

    • Completed medical oncology subspecialty at Kocaeli University
    • Over 27 years of experience of experience in internal medicine and oncology
    • Trained at Istanbul University's Cerrahpaşa Faculty of Medicine
  • Read more
Doctor's visit
Price on request

Nail Paksoy

  • 15 years of experience
  • accreditation:
  • Location: Turkey, Istanbul
  • Assoc. Prof. Nail Paksoy specializes in targeted therapies for lung cancer at Medipol Bahçelievler Hospital, with expertise in ALK-positive NSCLC treatments.

    • ESMO Board Certified in Medical Oncology
    • Subinvestigator in international clinical trials for ALK-positive NSCLC
    • Published research on real-world efficacy of ALK inhibitors
    • Medical Oncology Fellowship at Istanbul University Oncology Institute
  • Read more
Doctor's visit
Price on request

Muhammed Mustafa Atci

  • 15 years of experience
  • Location: Turkey, Istanbul
  • Associate Professor of Medical Oncology at İstinye University Liv Hospital Topkapı, specializing in targeted therapies for lung cancer.

    • Member of American Society of Clinical Oncology (ASCO) since 2018
    • Published multiple peer-reviewed articles on lung cancer treatment outcomes
    • Education Coordinator for Medical Oncology Sub-Branch
    • Extensive experience in both clinical and academic oncology roles
  • Read more
Doctor's visit
Price on request

Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.

Yan Matsiivskiy

Head of Medical Coordinator Team

4300++ patient journeys guided

3 years at Bookimed

278 patients from Turkey have found their doctor through us this month

How you'll get your perfect doctor match

1

2 min Quiz

Tell us your goal, budget, timeline

2

Human Matching + AI

Our algorithm finds matches, coordinator verifies fit

3

Your Options Ready

Compare prices, packages, dates. Chat with your coordinator

Overwhelmed by choices?

Your personal Bookimed coordinator helps you find the perfect surgeon tailored to your needs

  • Supports you 24/7 at every stage
  • Helps match you with the doctor and handles all communication with clinics
  • Coordinates your travel, accommodation, and transfers

Guiding your treatment

Medically trained personal coordinators

Peguy Beaugris
Tetyana Hyrych
Zekra Eldeeb
Victoria Olayinka
Iryna Sydorchuk
Tetiana Ihnatiuk

Choosing the Right Doctor and Clinic: Insider Tips

When selecting a doctor or clinic, keep these key points in mind:
Check credentials
Verify certifications from bodies like ISAPS, JCI, or relevant medical boards
Review success rates
Choose doctors with solid experience and a proven track record in your specific treatment.
Read patient reviews
Browse Bookimed reviews from real patients to learn about their experiences.
Ensure effective communication
Pick clinics that offer language support for a smooth treatment process.
Ask about services
Confirm whether the price includes services such as accommodation, local transfers, and follow-up care to avoid hidden costs.

Bookimed Insights: Top Target therapy for lung cancer Specialists in Turkey (2026)

Bookimed has coordinated 54035 requests for Target therapy for lung cancer in Turkey, collaborating with 9 top-rated specialists. The doctors in this table are selected based on their international credentials, clinical expertise, and patient outcomes. The 2026 ranking is formed using verified data from actual patient cases and current programs from our partner clinics.
RankDoctorexperienceGood Fit ForWhat Sets Them ApartClinic & LocationConsultation
#121 years of experienceTargeted lung cancer therapyExcels in targeted therapies and chemotherapy for lung cancer. Recognized nationally and involved in clinical research.
Turkey
from $215
#220 years of experienceTargeted therapy for lung cancerFellowship-trained at Hacettepe's prestigious Cancer Institute with additional training at MD Anderson. Specializes in precision oncology approaches.
Turkey
from $100
#32016 years of experienceLung cancer target therapySpecializes in precision oncology for lung tumors. Associate Professor with multi-hospital experience across Turkey's leading cancer centers.
Turkey
Price on request
#421 years of experienceAdvanced lung cancer casesFocuses on precision oncology with research in pharmaceutical biotechnology. ASCO & ESMO member ensuring global standard care. Professor training next-gen oncologists.
Turkey
Price on request
#527 years of experienceTarget therapy for lung cancerSpecializes in medical oncology with subspecialty training at Kocaeli University. Experienced in lung cancer treatment at VM Medical Park Pendik Hospital.
Turkey
Price on request
#615 years of experienceALK-positive NSCLCSpecializes in ALK-positive NSCLC with hands-on trial experience in next-gen ALK inhibitors. ESMO Board Certified with published real-world outcome studies.
Turkey
Price on request
#715 years of experienceTargeted lung cancer therapySpecializes in targeted lung cancer therapies with multiple peer-reviewed publications. ASCO member and academic leader in medical oncology education.
Turkey
Price on request

FAQ

These FAQs come from real patients seeking medical assistance through Bookimed. Answers are given by experienced medical coordinators and trusted clinic representatives.

Which leading oncologists in Turkey specialize in targeted therapy for lung cancer?

Leading oncologists in Turkey specializing in lung cancer targeted therapy include Dr. Mustafa Solak, Dr. Eda Tanrikulu, and Assoc. Prof. Nail Paksoy. These experts utilize molecular profiling to match patients with precision medications. Most hold international certifications and completed fellowships at prestigious cancer institutes globally.

  • Molecular specialization: Assoc. Prof. Nail Paksoy focuses on ALK-positive NSCLC and next-generation ALK inhibitors.
  • International training: Dr. Mustafa Solak completed specialized training at The University of Texas MD Anderson Cancer Center.
  • Academic expertise: Dr. Eda Tanrikulu is a former oncology head with extensive clinical trial experience.
  • Precision research: Prof. Cemil Bilir integrates pharmaceutical biotechnology research into advanced lung cancer treatment protocols.

Bookimed Expert Insight: Data shows that top Turkish oncologists like Dr. Eda Tanrikulu and Assoc. Prof. Nail Paksoy frequently participate in international clinical trials. This ensures patients access emerging therapies before they become widely available elsewhere. Choosing doctors at academic centers like Anadolu Medical Center or Istinye University Liv Hospital provides access to multidisciplinary tumor boards.

Patient Consensus: Patients emphasize the need for doctors who order molecular testing immediately to find specific mutations. They often mention that quick coordination between pathology and oncology is more vital than a doctor's fame. Many noted that successful treatment depended on the oncologist's willingness to perform a re-biopsy when the cancer changed.

How do Turkish lung cancer doctors determine if a patient is eligible for targeted therapy?

Turkish lung cancer doctors determine eligibility through comprehensive molecular profiling of tumor tissue or blood. Specialists identify specific genetic mutations like EGFR or ALK to match patients with precise treatments. This process avoids unnecessary chemotherapy by focusing only on drugs that target the tumor's unique DNA signature.

  • Molecular testing: Pathologists analyze biopsies for driver mutations such as ROS1, BRAF, and KRAS.
  • Next-generation sequencing: Centers like Acibadem use advanced sequencing to scan multiple genetic markers simultaneously.
  • Liquid biopsies: Doctors test blood samples for circulating tumor DNA if traditional biopsies are impossible.
  • Clinical assessment: Specialists verify if the patient can tolerate oral medications and matching drugs exist.

Bookimed Expert Insight: Turkish oncology stands out because leading specialists often combine domestic expertise with top-tier international training. For example, Dr. Mustafa Solak at Hisar Hospital practiced at MD Anderson, while Dr. Eda Tanrikulu at Anadolu trained at Oxford. This allows them to apply global precision medicine protocols using both RNA and DNA testing to ensure no gene fusions are missed.

Patient Consensus: Patients note that initial biopsies may not always include a full genetic panel unless specifically requested. They highlight the importance of obtaining the complete pathology report to confirm matching driver mutations. Many were surprised to learn that testing continues even after treatment begins to catch new mutations.

Do Turkish oncologists follow international protocols for targeted therapy management?

Turkish oncologists strictly adhere to international protocols for lung cancer management. Leading specialists utilize European Society for Medical Oncology (ESMO) and National Comprehensive Cancer Network (NCCN) frameworks. This ensures patients receive standardized precision care comparable to top institutions in the United States and Europe.

  • International certifications: Dr. Nail Paksoy holds ESMO Board Certification in Medical Oncology from Paris.
  • Global academic training: Dr. Mustafa Solak completed specialized training at the MD Anderson Cancer Center.
  • Precise molecular testing: Specialists at JCI-accredited hospitals use next-generation sequencing to identify specific tumor mutations.
  • Multidisciplinary review: Complex cases undergo evaluation by tumor boards to determine the best treatment sequence.

Bookimed Expert Insight: Data shows Turkish oncology attracts professors with extensive international research backgrounds. For instance, Prof. Cemil Bilir conducted pharmaceutical biotechnology research at Northeastern University in Boston. This academic integration means Turkish centers often provide access to advanced molecular insights before standard options are exhausted.

Patient Consensus: Patients emphasize the importance of having full molecular testing done before starting any drugs. Many felt more confident after seeing their cases reviewed by a team of different specialists. Direct explanations about which biomarkers were checked helped them understand the treatment plan better.

How do Turkish specialists coordinate treatment decisions for complex advanced lung cancer cases?

Turkish specialists coordinate complex lung cancer care through multidisciplinary tumor boards and integrated molecular diagnostics. These teams include medical oncologists, thoracic surgeons, and radiation experts who jointly review pathology. This collaborative framework ensures evidence-based decisions for advanced cases before systemic therapy begins.

  • Tumor board reviews: Weekly meetings unite various specialists to create a single synchronized treatment roadmap.
  • Genomic profiling: Experts like Dr. Eda Tanrıkulu evaluate EGFR, ALK, and ROS1 mutations.
  • Radiation coordination: Professors such as Berrin Pehlivan integrate stereotactic radiotherapy into systemic plans.
  • Global standards: JCI-accredited centers often maintain affiliations with prestigious institutions like Johns Hopkins Medicine.

Bookimed Expert Insight: Coordination in Turkey often centers on specialized molecular research hubs within hospitals. For instance, Dr. Muhammed Mustafa Atci and Professor Cemil Bilir combine academic research with clinical practice. This allows patients to access sequence-adjusted therapeutic models. These models may bypass traditional chemotherapy in favor of frontline targeted options based on real-time genomic data.

Patient Consensus: Patients note that getting molecular testing early is vital for successful targeted treatment decisions. They emphasize that the best results come from hospitals where specialists communicate directly. Many suggest bringing original biopsy blocks and digital scans to help teams verify previous findings quickly.

Can international patients communicate effectively with Turkish target therapy specialists?

International patients communicate effectively with Turkish lung cancer specialists through English-speaking doctors and dedicated care teams. Many oncologists hold European Society for Medical Oncology (ESMO) certifications. They often complete international fellowships. Private hospitals provide professional translators for and medical record coordination.

  • Specialist fluency: Top doctors often graduate from English-language medical programs or train at US-based centers.
  • Dedicated coordinators: Hospitals assign multilingual staff to assist with medical record translation and scheduling.
  • Global standards: Specialists follow international protocols from ESMO and ASCO, ensuring clear technical communication.
  • Academic expertise: Many professors publish research in English-language journals to maintain their prestigious board certifications.

Bookimed Expert Insight: Data shows that choosing doctors with international training, like Dr. Mustafa Solak who trained at MD Anderson or Dr. Cemil Bilir who conducted research at Northeastern University, often results in smoother communication. These specialists are accustomed to the precision required for discussing genetic biomarkers and complex targeted drug protocols with global patients.

Patient Consensus: Patients note that communication is most effective at major centers with established international departments. They often find that while the specialist speaks English, having a dedicated coordinator helps manage the smaller details of their treatment plan. Many emphasize the importance of having all biopsy and mutation reports translated before the first consultation.

How do Turkish doctors manage follow-up care for international targeted therapy patients?

Turkish oncologists manage follow-up through hybrid care models combining remote digital monitoring with scheduled clinical visits. They establish protocols for molecular testing and toxicity tracking. Local teams coordinate with home-country doctors to integrate reports and imaging results. Bookimed manages all logistics and scheduling for these transitions.

  • Molecular monitoring: Doctors schedule liquid biopsies or PET-CT scans to track tumor response and resistance.
  • Toxicity management: Specialists provide strict timelines for home-country blood tests to monitor liver and renal function.
  • Remote consultations: Patients access video appointments starting from $100 to review lab data and adjust dosages.
  • Documentation hand-off: International departments generate exhaustive English medical reports and mutation panels for local oncologists.

Bookimed Expert Insight: Leading oncology centers in Turkey often integrate research-level precision into follow-up care. For example, Dr. Eda Tanrikulu at Anadolu Medical Center has led international clinical studies, while Dr. Nail Paksoy at Medipol focuses specifically on next-generation ALK inhibitors. This expertise means follow-up plans are not just about checking stats, but anticipating exactly when a specific targeted agent might need switching based on published real-world outcomes.

Patient Consensus: Patients note the importance of securing a clear next steps document before leaving Istanbul. They emphasize that while WhatsApp and email help, having every imaging CD and English pathology report is vital for their home doctors. Most feel relieved when a concrete schedule for blood work and symptom triggers is clearly written out.